Fund Profile
Averis Ventures
Averis Ventures invests early in transformative healthcare companies, particularly those emerging in Israel, that are building platforms to translate complex biology into real clinical solutions. They focus on deep life science, bio-enabled platforms, and next-generation health systems, engaging with clinical reality and applying regulatory and adoption thinking from the start. They also leverage a strategic corridor into the DACH healthcare ecosystem for sourcing and allocation.
Investment thesis
Focus and thesis
Averis Ventures invests early in transformative healthcare companies, particularly those emerging in Israel, that are building platforms to translate complex biology into real clinical solutions. They focus on deep life science, bio-enabled platforms, and next-generation health systems, engaging with clinical reality and applying regulatory and adoption thinking from the start. They also leverage a strategic corridor into the DACH healthcare ecosystem for sourcing and allocation.
Profile links
Open the source pages
Partners and team
People behind the fund
- Fabio Kauermann
- Shani Amram
- Dr. Natanja Slager
Investor FAQ
Frequently asked questions
What is Averis Ventures' investment focus?
Averis Ventures invests early in transformative healthcare companies across deep life science, bio-enabled platforms, and next-generation health systems. This includes Deep Life Science & GenBio (Therapeutics, AI-native biology, diagnostics, modality-driven platforms), Bio-Enabled Platforms & Infrastructure (Drug discovery tools, bio-manufacturing, process analytics, data layers), and HealthTech (Clinical enablement, diagnostics-adjacent software, regulated care infrastructure).
Where does Averis Ventures primarily invest?
Averis Ventures primarily invests in Israel, focusing on early-stage companies in the healthcare sector. They also maintain a strategic corridor into the DACH (Germany, Austria, Switzerland) healthcare ecosystem for co-investment opportunities.
What is Averis Ventures' approach to early-stage investing?
Averis Ventures combines early institutional capital with hands-on involvement through critical early stages. They aim to help companies make better early decisions, build toward real adoption, and develop with long-term relevance in mind, working within the complexity of healthcare rather than avoiding it.
Who are the partners at Averis Ventures?
The partners at Averis Ventures include Fabio Kauermann, an investment banking and VC professional, and Shani Amram, a CPA and MBA with extensive experience in private equity investments. Dr. Natanja Slager serves as a Strategic Advisor & IC Member.
